MORT1/FADD is involved in liver regeneration

World J Gastroenterol. 2005 Dec 14;11(46):7248-53. doi: 10.3748/wjg.v11.i46.7248.

Abstract

Aim: To explore the role of the adaptor molecule in liver regeneration after partial hepatectomy (PH).

Methods: We used transgenic mice expressing an N-terminal truncated form of MORT1/FADD under the control of the albumin promoter. As previously shown, this transgenic protein abrogated CD95- and CD120a-mediated apoptosis in the liver. Cyclin A expression was detected using Western blotting. ELISA and RT-PCR were used to detect IL-6 and IL-6 mRNA, respectively. DNA synthesis in liver tissue was measured by BrdU staining.

Results: Resection of 70% of the liver was followed by a reduced early regenerative response in the transgenic group at 36 h. Accordingly, 36 h after hepatectomy, cyclin A expression was only detectable in wild-type animals. Consequently, the onset of liver mass restoration was retarded as measured by MRI volumetry and mortality was significantly higher in the transgenic group.

Conclusion: Our data demonstrate for the first time an involvement of the death receptor molecule MORT1/FADD in liver regeneration, beyond its well described role as part of the intracellular death signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / physiology*
  • Animals
  • Apoptosis
  • Cell Proliferation
  • Cyclin A / metabolism
  • Fas-Associated Death Domain Protein
  • Hepatectomy
  • Interleukin-6 / genetics
  • Interleukin-6 / metabolism
  • Liver Regeneration / physiology*
  • Male
  • Mice
  • Mice, Transgenic
  • Peptide Fragments / genetics
  • Peptide Fragments / physiology

Substances

  • Adaptor Proteins, Signal Transducing
  • Cyclin A
  • Fadd protein, mouse
  • Fas-Associated Death Domain Protein
  • Interleukin-6
  • Peptide Fragments